Research & Innovation | National Cancer Centre Singapore

Research Cellular & Molecular Research The Division of Cellular & Molecular Research is focused on understanding the mechanistic basis of tumour development and treatment response; as well as the translation of bench-based findings to devise strategies to improve the early detection and treatment of cancers.

Research Medical Sciences The Division of Medical Sciences has evolved in the last decade to one that is completely focused on the mission of translating biological discoveries into the clinic.

Research Clinical Trials & Epidemiological Sciences The Division was conceived to provide support and to encourage clinical trials within NCCS.

Research Facilities

With almost 10,000 square metres of research space, NCCS houses advanced translational research facilities for scientists and clinician-scientists in Singapore.

Clinical Trials

At NCCS, clinical trials are led by a highly-trained multidisciplinary team of clinicians, researchers, nurses and support staff experienced in managing the protocol and delivery of local and international trials.

Our Researchers

Meet our researchers, driving innovation and uncovering groundbreaking discoveries every day.

Find a Researcher

Discover our expert researchers and their groundbreaking work in cancer, from bench to bedside, at NCCS.

Research Themes and Core Platforms

Explore our dynamic research programmes, actively pushing boundaries and sparking transformative solutions.

NCCS Research Reports

Dive into our insightful research reports, actively shaping knowledge and driving impactful discoveries.

NCCS Research Committee & Scientific Advisory Board

Research News

Research New therapy shows promise in treating advanced HER2 mutated lung cancer A global, multicentre, phase 1/2 clinical trial that included clinician-scientists and researchers from MD Anderson Cancer Centre, Seoul National University and the National Cancer Centre Singapore has indicated positive results in treating advanced HER2-mutant non-small-cell lung cancer (NSCLC) with sevabertinib, an oral HER2-targeted tyrosine kinase inhibitor.

21 Oct 2025 Read Story

Research Singapore scientists preserve lymph nodes outside body to test vaccines SINGAPORE – Singapore researchers have managed to extend the lifespan of lymph nodes outside the body, allowing them to study how the immune system reacts to vaccines and immunotherapies.

08 Sep 2025 | The Straits Times Read Story

View All News